- Home
- SLM vs BIO Comparison
SLM vs BIO Comparison
Compare SLM & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLM
- BIO
- Stock Information
- Founded
- SLM 1972
- BIO 1952
- Country
- SLM United States
- BIO United States
- Employees
- SLM N/A
- BIO N/A
- Industry
- SLM Finance: Consumer Services
- BIO Biotechnology: Laboratory Analytical Instruments
- Sector
- SLM Finance
- BIO Industrials
- Exchange
- SLM Nasdaq
- BIO Nasdaq
- Market Cap
- SLM 7.2B
- BIO 6.2B
- IPO Year
- SLM N/A
- BIO N/A
- Fundamental
- Price
- SLM $32.37
- BIO $226.40
- Analyst Decision
- SLM Buy
- BIO Strong Buy
- Analyst Count
- SLM 11
- BIO 4
- Target Price
- SLM $31.55
- BIO $330.50
- AVG Volume (30 Days)
- SLM 2.0M
- BIO 374.2K
- Earning Date
- SLM 07-23-2025
- BIO 07-31-2025
- Dividend Yield
- SLM 1.61%
- BIO N/A
- EPS Growth
- SLM N/A
- BIO N/A
- EPS
- SLM 2.78
- BIO N/A
- Revenue
- SLM $1,449,130,000.00
- BIO $2,541,100,000.00
- Revenue This Year
- SLM $7.60
- BIO N/A
- Revenue Next Year
- SLM $9.61
- BIO $3.69
- P/E Ratio
- SLM $11.63
- BIO N/A
- Revenue Growth
- SLM N/A
- BIO N/A
- 52 Week Low
- SLM $19.39
- BIO $215.38
- 52 Week High
- SLM $34.55
- BIO $387.99
- Technical
- Relative Strength Index (RSI)
- SLM 53.17
- BIO 41.49
- Support Level
- SLM $32.52
- BIO $220.31
- Resistance Level
- SLM $34.55
- BIO $233.28
- Average True Range (ATR)
- SLM 0.83
- BIO 8.26
- MACD
- SLM -0.22
- BIO -1.40
- Stochastic Oscillator
- SLM 11.38
- BIO 16.29
About SLM SLM Corporation
SLM Corp is an education solutions company. It business is to originate and service loans to students and their families to finance the cost of their education. The provide Private Education Loans to mean education loans to students or their families that are not made, insured, or guaranteed by any state or federal government.
About BIO Bio-Rad Laboratories Inc.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.